Joint Formulary & PAD

Disopyramide - Arrhythmias

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Blue
Formulations :
  • Capsules
Associated Icons :
Restrictions / Comments :
Important
Specialist initiation and at least one month supply before transfer to primary care
 

Status 2

Blue
Formulations :
  • Modified release tablets
Associated Icons :
Restrictions / Comments :
Important
Specialist initiation and at least one month supply before transfer to primary care

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Disopyramide
Indication :
Arrhythmias
Group Name :
Keywords :
Brand Names Include :
Rythmodan
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0
Traffic Light Entries :
2

Other Indications

Below are listed other indications that Disopyramide is used to treat.

  • No records returned.

Committee Recommendations (1)

The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.